AI-guided experiments find mRNA formulations active after warm storage
A peer-reviewed study used AI-guided experiments to find solid-state mRNA formulations that retained bioactivity after more than two months at 37°C, with evidence still confined to laboratory and animal work.
An MIT-led study published in Nature Biotechnology on September 28 reports experimental mRNA formulations that retained activity during prolonged warm storage.
It addresses one constraint on a vaccine’s journey: preserving bioactivity before administration.
The team’s AGENT system combines laboratory screening with Bayesian optimization, which uses previous experimental results to choose informative next candidates. Six rounds within a month produced solid-state formulations reported to retain bioactivity after more than two months at 37°C. Animal experiments also found antigen-specific immune responses comparable to fresh formulations.
The result is promising preclinical evidence. It does not establish human efficacy, an approved vaccine, or new storage instructions for products already in use. Retained activity in an experiment is a specific measurement; a deployable vaccine would have to satisfy further requirements that this report does not settle.
For researchers, the immediate resource is the public data record. It lists three spreadsheets covering optimization, storage and nonhuman-primate antibody measurements. The July 31 deposit predates today’s publication; the news is the peer-reviewed account, rather than a newly released dataset.
Start with the experimental comparisons and ask exactly how activity was measured before adopting the workflow. We inspected the public abstract, availability statements and dataset listing. The full main text and supplementary methods were not available for review, so sample sizes and detailed experimental controls remain unchecked here. That limit is why this report stops short of a full technical interpretation.
Sources & details 3 sources
Discuss in your voice app
Take the reporting, visual explanations and original sources into a conversation. Copy the brief, paste it into your preferred assistant, then start its voice mode.
Paste the brief into your voice app to discuss this reporting.Revised 4 October 2026. Reporting and visuals refined. Original source dates and prior checks retained.
Reporting sources
- Nature Biotechnology — original study
Published September 28. Public abstract, peer-review record, availability statements and disclosures inspected; main text paywalled.
- Zenodo — experimental datasets
Three public spreadsheet files listed; deposited July 31. Their analysis was not independently reproduced.
- AutoOED — optimization code
Existing optimization software linked by the paper; not a new software release.
Images & figures
Measurements guided the next experiments through six optimisation rounds within a month. Selected formulations retained bioactivity after more than two months at 37°C. This is preclinical evidence: warm-storage activity and animal responses do not establish human efficacy, and detailed methods were unavailable for this report.